Stocks / BMRN vs EHC

BMRN vs EHC

BioMarin Pharmaceutical Inc. and Encompass Health Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

BMRN is the larger company ($10.9B vs $10.1B). On the fundamentals, BMRN grows revenue faster (11.6% vs 10.7%); BMRN earns a higher net margin (10.8% vs 9.5%); EHC has the stronger return on equity (23.2% vs 5.7%). Full numbers below — the stronger figure on each row is in green.

	BioMarin Pharmaceutical Inc. (BMRN)	Encompass Health Corporation (EHC)
Market cap	$10.9B	$10.1B
Revenue (latest FY)	$3.22B	$5.94B
Net income (latest FY)	$348.90M	$566.20M
Revenue growth (5y CAGR)	11.6%	10.7%
Net margin	10.8%	9.5%
Return on equity	5.7%	23.2%
P/E ratio	40.4	17.5
Dividend yield	—	0.7%
Profitable years (of last 10)	5	10
Positive free cash flow	Yes	Yes

Compare with another company:

See the full BMRN vs EHC breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open BMRN's full financials → Open EHC's full financials →

More comparisons

BMRN vs RVTY BAX vs EHC BMRN vs MDGL EHC vs MOH BMRN vs GMED ARWR vs EHC BMRN vs ICLR EHC vs PODD

Frequently asked questions

Which is bigger, BMRN or EHC?

BioMarin Pharmaceutical Inc. is larger by market capitalization — $10.9B versus $10.1B.

Which grows faster, BMRN or EHC?

Over the last five fiscal years, BioMarin Pharmaceutical Inc. grew revenue faster — 11.6%/yr versus 10.7%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

Quality compounders →

BMRN fundamentals → · EHC fundamentals → · All 1,500+ companies → · Free screener →